Sign in
Explore the registryTrack Ritlecitinib's trials

Tranquillo 2

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

RitlecitinibOngoingActive not recruitingPhase 3Open NCT06072183 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…